Clinionco-Clinica de Oncologia de Porto Alegre

Porto Alegre

0 studies enrolling now · 1 studies all time

What they study most

Cancer

Studies at this site

• Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer — Completed